Latest Breaking News On - Against aspergillosis - Page 1 : comparemela.com

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Irina kofflerAshraf ibrahimDrug administrationGlobenewswire incExchange commissionDivision of infectious diseasesLundquist instituteDavid geffen school of medicineScynexis incInfectious diseasesGeffen schoolAgainst aspergillosisInfectious disease productFast trackPrivate securities litigation reform actAnnual report

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

JERSEY CITY, N.J., Jan. 05, 2024 SCYNEXIS, Inc. , a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today.

Irina kofflerDavid anguloAshraf ibrahimNational institutes of healthExchange commissionNational institute of allergyDivision of infectious diseaseScynexis incDavid geffen school of medicineGlobenewswire incDrug administrationAgainst aspergillosisInfectious diseaseGeffen schoolChief executive officerInfectious diseases